Autopsy report · NCT01020513

Subcutaneous Recombinant Human Hyaluronidase: Workflow Analysis and Emergency Department Design

“This study was closed before accrual due to FDA recall of Medication”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

University of California, San Diego

Sponsor type

University, hospital or other

Conditions

Dehydration

Participants

0

Trials that died the same way

• Exenatide For Reducing the Reinforcing Effects of Cocaine
  “The study was closed due to the inability to acquire the study drug.” (76% match in meaning)
• Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates
  “FDA drug recall on July 30, 2010” (73% match in meaning)
• Safety of SP-420 in the Treatment of Transfusional Iron Overload
  “Study is on hold by FDA in the US.” (72% match in meaning)
• Maternal Epidural Steroids and Hyperthemia
  “PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study is closed” (71% match in meaning)
• Panobinostat/Velcade in Multiple Myeloma
  “This study was terminated because the drug company stopped making the study drug” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.